Journal: Oncology Research
Article Title: MicroRNA-373 Promotes Growth and Cellular Invasion in Osteosarcoma Cells by Activation of the PI3K/AKT–Rac1–JNK Pathway: The Potential Role in Spinal Osteosarcoma
doi: 10.3727/096504016X14813867762123
Figure Lengend Snippet: miR-373 activates the PI3K/AKT–Rac1–JNK pathway of the MG-63 cell line. (A) The effect of aberrant miR-373 on the PI3K/AKT pathway of the MG-63 cell line. (B) The effect of aberrant miR-373 on Rac1 and JNK of the MG-63 cell line. (C) The effect of overexpressing miR-373 on the PI3K/AKT–Rac1–JNK pathway with the PI3K/AKT inhibitor LY294002. (D) The effect of overexpressing miR-373 on the PI3K/AKT–Rac1–JNK pathway with the Rac1 inhibitor NSC23766. miR, microRNA; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; PI3K, phosphoinositide 3-kinase; GTP, guanosine triphosphate; Rac1, Ras-related C3 botulinum toxin substrate 1; JNK, c-Jun N-terminal kinase.
Article Snippet: Thereafter, cells were exposed to the phosphoinositide 3-kinase (PI3K) LY294002 inhibitor (10 μM; Sigma-Aldrich, St. Louis, MO, USA) or the Ras-related C3 botulinum toxin substrate 1 (Rac) guanosine triphosphate (GTPase) NSC23766 inhibitor (50 μM; Calbiochem, San Diego, CA, USA) for 24 h.
Techniques: